Project Grant CLSS00000062603

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

The U.S. Department of Justice's Bureau of Justice Assistance awarded a $7,000,000 Project Grant under the Comprehensive Opioid, Stimulant, and Other Substances Use Program (CFDA 16.838) to the Connecticut Department of Mental Health and Addiction Services (DMHAS). The grant will support community-based opioid overdose response efforts in Western Connecticut, including: enhancing reentry services, providing support for drug-impacted children, expanding drug analysis to understand emerging drug...

This federal Project Grant award from the National Center for Injury Prevention and Control, under the Drug-Free Communities (DFC) Support Program (CFDA 93.276), provides $125,000 annually over a 5-year period to Healing In The Hood Inc., a minority-owned non-profit organization in Blytheville, Arkansas. The funding enables the organization to lead the Opioid Prescription Drug and Synthetics (O.P.P.S.) Coalition, which aims to reduce youth (ages 12-18) use of marijuana and misuse of...

The National Institute on Drug Abuse (NIDA) awarded a $220,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Amalgent Therapeutics, Inc. in Greenville, NC. This grant supports the development of a novel opioid adjuvant technology that aims to enhance the pain-relieving efficacy of opioid medications while mitigating risks such as abuse potential, tolerance, and neuropathic pain. The project has two key objectives: 1) investigating the mechanism by which the...

The U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $238,107,340 Project Grant under the Opioid State Targeted Response (Opioid STR) program (CFDA 93.788) to the Massachusetts Department of Public Health (MDPH). The grant aims to address the opioid crisis in Massachusetts by increasing access to FDA-approved medications for opioid use disorder treatment, as well as supporting the continuum of prevention, harm reduction,...

The National Institute on Drug Abuse (NIDA) awarded a $267,000 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to The Children's Hospital Corporation (dba Boston Children's Hospital) to develop depot formulations for on-demand, tamper- and diversion-proof delivery of opioids. The project aims to create polymer-based injectable depot formulations that covalently bind opioids via photolabile linkers, making them difficult to tamper with or divert. Once administered, the...

The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program, awarded a $800,000 Project Grant to the City of Altus, doing business as Altus Power, to address the opioid epidemic in the community. The project, titled "Project VIOLET - Bridging the Gaps; Fighting the Opioid Epidemic Head On, One Person at a Time," focuses on several key initiatives: Recruiting and training...

The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $598,312 to Addinex Technologies, Inc. to integrate and assess the practicality of a closed-loop medication management system for opioid pain management in ambulatory patients with extremity fractures being discharged from the emergency department. The key objectives are to: 1) Adapt the Addinex system to seamlessly integrate with hospital pharmacy...

The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $1,000,000 Project Grant under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program to the Village of Alakanuk in Alaska. This 5-year grant will fund the Alakanuk Tribal Opioid Response Program, which aims to implement culturally informed and responsive community and school-based prevention education activities to raise awareness about the dangers of...